FindTrial
Sign In

Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04457999
Enrollment
100
Registered
2020-07-07
Start date
2020-03-20
Completion date
2020-07-30
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease

Interventions

DEVICELipiflow Thermal pulsation

Single vectored thermal pulsation treatment for dry eye

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients older than 21, who will get catarct surgeyr * Patients whose visual acuity anticipated better than 20/25 after surgery * Patients with informed consent * Patients with meibomian gland dysfunction

Exclusion criteria

* ocular injury, active injection * uncontrolled systemic disease * Contact lens wear within 1 month * Allergic to fluorescein sodium or topical anesthetics * ocular surgery or trauma within 6 months * disorder of lid anatomy * other reason for decreased vision other than cataract * anticipated visual acuity less than 20/25 * Patients less than 20 years.

Design outcomes

Primary

MeasureTime frameDescription
improvement of dry eye symptom1 monthocular dryness

Countries

South Korea

Contacts

Primary ContactTae-Young Chung, MD. PhD
tychung@skku.edu82-2-3410-3563

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026